area CA1 are normal, but the PS1 cKO mice exhibit
Generation and Characterization
To determine whether the introduction of the loxP of the PS1 cKO Mouse sites into PS1 introns affects transcription and/or splicTo achieve the selective disruption of PS1 in the cerebral ing of PS1 mRNA, we performed Northern and RT-PCR cortex (neocortex and hippocampus) during postnatal analyses and found that the level and the size of PS1 life, we employed the recently developed Cre/loxP retranscripts are unaltered in homozygous fPS1 mice (Figcombination technology. We first generated a floxed ure 2A and data not shown). The homozygous PS1 ⌬ mice PS1 mouse, in which PS1 exons 2 and 3 are flanked by exhibit phenotypes indistinguishable from those of the two loxP sites ( Figure 1A ). Using homologous recombi-PS1 Ϫ/Ϫ mice that we previously reported, confirming nation in embryonic stem (ES) cells, we generated a that excision of the floxed region results in a PS1 null modified PS1 allele, in which a loxP site and a floxed allele . Northern analysis of PS1 ⌬ mice drug selection cassette were introduced into PS1 inrevealed greatly reduced levels of a smaller PS1 trantrons 1 and 3, respectively ( Figure 1A ). The floxed PS1 script, indicating that the PS1 transcript lacking exons 2 allele (fPS1) and the PS1 ⌬ allele were then generated by and 3 is highly unstable or that important transcriptional transient transfection of a cDNA encoding Cre recombiregulatory sequences reside within this region ( Figure 2A ). nase, which mediates site-specific recombination beSpatial and temporal inactivation of PS1 expression tween two loxP sites . ES cells carrying in cKO mice was examined by Northern, Western, and either the fPS1 or the PS1 ⌬ allele were injected into in situ hybridization analyses. Northern analysis showed mouse blastocysts to generate chimeric mice, which a marked reduction in the level of PS1 mRNA in the were then used to generate heterozygous and homozycortex (neocortex and hippocampus) of cKO mice at the age of 6 weeks, though residual PS1 transcripts were gous fPS1 and PS1 ⌬ mice. We also generated a Cre (A) Northern analysis of PS1 transcripts in fPS1/fPS1, PS1 ⌬/⌬ , and PS1 cKO mice. Total RNA was prepared from the brains of fPS1/fPS1 and littermate control (ϩ/ϩ) mice at the age of 6 weeks (lanes 1 and 2), the brains of PS1 ⌬/⌬ and littermate control (ϩ/ϩ) mice at embryonic day 18 (lanes 3 and 4), and the cortex (neocortex and hippocampus) of cKO (PS1 ⌬ /fPS1;CaM-Cre) and littermate control (fPS1/ϩ) mice at the age of 6 weeks (lanes 5 and 6), and then hybridized with a PS1 cDNA probe. The same blot was then hybridized with a control probe, GAPDH, to normalize the amounts of RNA in each lane. (B) Progressive elimination of PS1 CTFs in the cKO cortex. Brain homogenate from the cortex of cKO (PS1 ⌬ /fPS1;CaM-Cre) and littermate control (C) (fPS1/ϩ or fPS1/fPS1) mice at the ages of P18, P22, 6 weeks, and 6 months was immunoblotted with antiserum raised against the loop region of PS1 (Thinakaran et al., 1996). The blot was then incubated with ␤-tubulin antibody to normalize the amounts of protein in each lane. (C) In situ hybridization analysis of PS1 expression in the neocortex and hippocampus of PS1 cKO and control mice. Sagittal brain sections (10 m) of PS1 cKO (PS1 ⌬ /fPS1;CaM-Cre) and littermate control (PS1 ⌬ /fPS1) mice at the age of 3 months were hybridized with a digoxigeninlabeled probe specific for PS1 exons 2 and 3. Expression of PS1 transcripts is largely eliminated in the hippocampus and neocortex of the PS1 cKO brain. (D) Normal gross morphology of the hippocampus and neocortex of the cKO mouse. Sagittal brain sections (12 m) of PS1 cKO and littermate control mice at the age of 3 months were stained with cresyl violet. The gross morphology of the cKO brain is indistinguishable from that of the control. still detectable (Figure 2A ). Since the majority of endogesitu hybridization on brain sections of PS1 cKO and control mice at the age of 3 months using a digoxigeninnous PS1 undergoes endoproteolytic processing into 27 kDa N-terminal and 18 kDa C-terminal fragments labeled probe specific for PS1 exons 2 and 3. We found that PS1 is expressed at high levels in the hippocampus (CTF), we examined the level of PS1 CTF by Western analysis. The level of PS1 CTF in the cortex is slightly and at lower levels in the neocortex of the control brain, while its expression in the cKO brain is eliminated (Figreduced at postnatal day 18 (P18) and further reduced at P22 ( Figure 2B ). By the ages of 6 weeks and 6 months, ure 2C). In contrast to PS1 Ϫ/Ϫ mice, the PS1 cKO mouse is very low levels of PS1 CTF were detected in the cortex of cKO mice, while the level of PS1 CTF was unchanged viable with no obvious phenotypic abnormalities. Nissl staining of the brain sections of cKO mice at the ages in the cerebellum and brain stem ( Figure 2B and data not shown). These results indicate a selective elimination of of P18, 20, 22, and 3 months ( Figure 2D ) also revealed no gross abnormalities. Despite large numbers of re-PS1 expression in the cortex of PS1 cKO mice beginning at P18. The residual amount of PS1 observed in the ports that have suggested a role for PS1 in apoptosis using various cell culture systems, we failed to detect cortex of cKO mice is due to its expression in glial cell types (Lah et al., 1997) and possibly a small population of an increase in apoptosis in the cerebral cortex of cKO mice. Bisbenzimide staining and TUNEL analysis of the neurons lacking Cre expression. We further performed in , 1996) . rum specific for ␤-APPs also showed similar levels of To quantify the increase of the APP CTFs, we perthe ␤-APPs in the cKO cortex compared to the control formed Western analysis using serial dilutions of cKO ( Figure 3D ). These results indicate that PS1 is not inbrain lysate at the age of 6 months ( Figure 4B ). We volved in the regulation of ␣-and ␤-secretase cleavage estimate that the levels of C83 and C89 are increased of APP.
approximately 30-fold, relative to the control, while the We then performed Western analysis using an antiserum ("Saeko") raised against the C-terminal region of increase in the level of C99 is approximately 3-fold. Since Relative levels of mouse A␤40 and A␤42 in the cortex of the cKO (n ϭ 9) and control (n ϭ 9) mice at the age of 3-6 months were determined by the BNT-77/BA27 and BNT-77/BC05 ELISA assays following immunodepletion of the APP CTFs using the "Saeko" antiserum, respectively. Levels of A␤40 and A␤42 in the cKO cortex are shown as relative values to that of the control, which are designated as 1. (D) Reduction of human A␤40 and A␤42 peptides in the cKO cortex. The level of human A␤40 and A␤42 in the cortex of the cKO (n ϭ 7) and control (n ϭ 6) mice at the age of 6-9 weeks was measured by the 2G3/3D6 and 21F12/3D6 ELISA assays, respectively. In the control mice overexpressing human mutant APP, levels of human A␤42 are slightly higher than that of A␤40, most likely due to the Indiana mutation that is known to increase the production of A␤42. In the cKO mice overexpressing human mutant APP, levels of both A␤40 and A␤42 are significantly reduced (p Ͻ 0.01, Student's t test). The reduction of A␤40 ‫)%24ف(‬ is more marked than that of A␤42 ‫)%72ف(‬ in the cKO cortex. elimination of PS1 expression does not affect ␣-and showed that neither BA27 nor BC05 recognizes the high levels of the accumulated CTFs in the PS1 cKO cortex ␤-secretase cleavages, these results indicate that PS1 is required for ␥-secretase activity, and that lack of PS1 (data not shown). Immunoprecipitation using either BA27 or BC05 followed by Western analysis, however, results in accumulation of ␥-secretase substrates.
To investigate PS1 function in the generation of A␤ revealed that BC05 crossreacts with the APP CTFs, while BA27 does not, suggesting that levels of A␤42 peptides in the adult cerebral cortex, we measured levels of A␤40 and A␤42 in the cortex of the cKO and the littermate control mice at the ages of 6 weeks and 6 cKO mice at both ages examined (Table 1) . Surprisingly, (n ϭ 4 ea.)
we detected higher levels of A␤42 in the cortex of cKO detected by BC05 may be artificially elevated in the cKO Notch downstream target genes, Hes1, Hes5, and Dll1. Northern analysis of poly(A) ϩ RNA derived from the corcortex due to the presence of high levels of the APP CTFs. To measure levels of A␤40 and A␤42 accurately, tex of cKO and littermate control mice at the age of 6 weeks showed similar levels of Hes1, Hes5, and Dll1 we removed the APP CTFs from the lysate by immunodepletion using the "Saeko" antiserum, and then deterexpression ( Figure 5 ). Quantitative comparison of the level of the Hes1, Hes5, and Dll1 transcripts in the cortex mined the level of A␤40 and A␤42 in the supernatant by ELISA ( Table 2 ). The complete removal of the CTFs in of multiple mice (n ϭ 4-5) from multiple experiments (n ϭ 3) confirmed normal expression of these Notch the supernatant was confirmed by Western analysis. Using this method, we found that the level of both A␤40 downstream target genes in the cKO cortex. These reand A␤42 is reduced in the cKO cortex relative to the control (Table 2, Figure 4C ). We recently generated cKO mice that overexpress the human mutant APP containing the Swedish and the Indiana (V717F) mutations (Mucke et al., 2000) . The level of human A␤40 and A␤42 was determined by ELISA assays using antibodies that are specific for human A␤40 and A␤42 peptides and do not crossreact with APP CTFs (Johnson-Wood et al., 1997). We found that the level of human A␤40 and A␤42 is also reduced in the cKO cortex ( Figure 4D ). Together, our results showed that elimination of PS1 expression in most neurons of the adult mouse cerebral cortex markedly reduces the production of A␤ peptides, supporting the notion that targeting PS1 is an effective strategy for anti-amyloidogenic therapy in AD. Figure 7D ). LTD has been proposed to provide a complementary mechanism to LTP for the bidirectional in the embryonic brain relative to PS1, are sufficient to modulation of synaptic efficacy (Bear, 1999). To investigate further whether PS1 plays a role in the modulation of synaptic plasticity in hippocampal area CA1, we induced LTD with a paired-pulse low frequency stimulation (ppLFS), a protocol effective in inducing LTD in slices from mature mice (Krezel et al., 1999) . As shown in Figure 7E , the magnitude of LTD (measured 60 min after conditioning) was identical in the PS1 cKO (78 Ϯ 4) and the control (78 Ϯ 4; p ϭ 0.94) ( Figure 7E ). These results demonstrate that PS1 is not required for the induction and maintenance of LTP and LTD in the Schaeffer collateral pathway of the hippocampus.
Normal Expression of Notch Downstream Effector Genes

Subtle Long-Term Spatial Memory Deficits in PS1 cKO Mice
To assess the neuronal function of PS1 more globally, we used the Morris water maze task, a hippocampusdependent paradigm for spatial learning and memory (Morris et al., 1982) . During the acquisition phase of the task, mice learn the position of a hidden escape platform in a circular pool using distal spatial cues. Their performance is measured by the time required to locate the platform (escape latency) and by the distance traveled to reach the platform (path length). During the first 7 days of training, both groups of mice improved their performance at a similar rate, as indicated by the decreasing escape latencies and path lengths (Figures 8A  and 8B ). However, during the last 3 to 5 days of training, the control mice continued to improve while the performance of the cKO mice plateaued, resulting in significantly longer escape latencies and path lengths for the cKO group (Figures 8A and 8B) . A two-way ANOVA showed a significant interaction effect of group x days (F(9,261) ϭ 2.06; p ϭ 0.03). Subsequent pairwise comparisons (Student's t tests) showed significantly longer latencies and path lengths for the cKO group versus the control group on days 8, 9, and 10 (t(29); p Ͻ 0.05). Swimming speed and the degree of thigmotaxis (wall hugging) were similar in the cKO and control mice (data not shown), arguing against nonspecific effects due to impaired motor function and/or anxiety.
The PS1 cKO and control mice were further tested in probe trials, in which the platform is removed from the (Figure 7) . However, the Morris water unclear, the striking accumulation of the APP CTFs in maze task revealed a mild delayed deficit in spatial learnthe cortex of PS1 cKO mice may disrupt these coming and memory in the PS1 cKO mice (Figure 8) . Although plexes and lead to deficits in synaptic function. the performance of the cKO mice during initial stages In summary, our analysis of the PS1 cKO mice proof learning was not significantly different from that of vides direct in vivo evidence of the requirement for PS1 the control mice, the performance of the cKO mice plain normal APP processing and the generation of amyloid teaued during the later stages of this reference memory peptides. Surprisingly, the regulation of the Notch downtask, while the control mice continued to improve (Figure stream genes in the adult brain is independent of PS1, 8). In addition, the platform crossings of the cKO mice in contrast to the regulation of Notch activity by PS1 were much lower than the control in the probe trial after during brain development. It is therefore likely that thera-10 days of training, but the target quadrant occupancy peutic ␥-secretase inhibitors will be able to achieve rewas similar in both groups of mice. The cKO mice are duced production of A␤ peptides in the adult brain withthus able to learn the general location of the platform, out unwanted side effects on the expression of the but with less spatial precision than the control mice.
Notch target genes. PS1 also appears to be required These findings suggest a deficit in detailed spatial navifor normal neuronal function in the adult brain, but the gation in the cKO mice, though gross spatial navigation observed cognitive deficits in the PS1 cKO mice are is normal.
relatively subtle and may be restricted to specific neural The platform-reversal phase of the task also elicited circuits. In support of this notion, synaptic transmission a poorer performance by the cKO mice in the escape and plasticity in hippocampal area CA1 of the cKO mice latencies and path length from the first training day, was entirely normal. It will be important, however, to indicating a mild learning deficit (Figure 8) . The identical determine whether mice lacking both presenilins exhibit performance by the cKO and control mice in the visible any additional abnormalities since therapeutic ␥-secreplatform task indicates that the deficits exhibited by the tase inhibitors are likely to inhibit both PS1-and PS2-cKO are due to spatial learning and memory rather than mediated activities. Based on our current study, the a visual, motor, or motivational impairment. Elimination benefits of therapeutic ␥-secretase inhibitors may outof PS1 expression in the adult cortex thus leads to subtle weigh the potentially detrimental effects associated with but significant deficits in learning and memory, indicattargeting PS1 function. ing a requirement for PS1 in normal neuronal function. The normal synaptic transmission and plasticity in the 
